SCHEMBL19146269

SCHEMBL19146269

B[C@@H]1O[C@H](CO)C(N)[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20654927 1.00 — —
SCHEMBL12049857 0.85 L3MBTL1 (0.31) —
SCHEMBL12769537 0.85 L3MBTL1 (0.31) —
SCHEMBL10072846 0.83 — —
SCHEMBL21563220 0.81 LGALS8 (0.31) —
SCHEMBL12990383 0.81 LGALS8 (0.31) —
SCHEMBL14643902 0.79 — —
SCHEMBL12583008 0.79 L3MBTL1 (0.33) —
SCHEMBL20655073 0.79 — —
SCHEMBL13818671 0.79 L3MBTL1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017123669-A1 CYCLIC DINUCLEOTIDES FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY SUCH AS CANCER GLICK GARY (US) 2017-07-20 — — WO disclosed
Send feedback